Uric Acid and Routine Laboratory Variables, but Not Mitochondrial DNA Copy Number, Independently Predict Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Prospective Cohort Study
Objective: Intravenous immunoglobulin (IVIG) resistance affects 10–20% of children with Kawasaki disease (KD) and identifies patients at high risk of treatment failure. We previously showed that peripheral blood mitochondrial DNA copy number (mtDNA-CN) predicts persistent coronary artery dilation. Here we comprehensively evaluated the predictive value of mtDNA-CN for IVIG resistance using a prespecified, multistep analytical strategy and constructed a validated clinical prediction model from routine laboratory variables. Methods: In this prospective single-center cohort (West China Second University Hospital, March 2020 to March 2022), 134 children with KD were analyzed at the patient level. mtDNA-CN was quantified by qPCR before IVIG. Because the leukocyte differential and its percentages vary physiologically with age in young children, absolute leukocyte counts and derived indices, rather than differential percentages, were used in the primary analysis, and age-adjusted and age-restricted (<5 years) sensitivity analyses were performed. Analyses included univariable and multivariable logistic regression with cluster-representative backward AIC selection (mtDNA-CN forced in, robust standard errors), multiple imputation (m = 20), LASSO-penalized regression, restricted cubic splines, interaction and subgroup analyses, bootstrap internal validation (2000 resamples), incremental value analysis (DeLong test, ΔAUC, IDI, NRI), comparison with a Kobayashi-like clinical score, and decision curve analysis. Results: Forty-four patients (32.8%) were IVIG resistant. In univariable analysis, lower mtDNA-CN was borderline associated with resistance (OR 0.36, 95% CI 0.13–1.00, p = 0.050). In the final multivariable model (complete-case n = 133, 43 events), lower uric acid (OR 0.9865 per μmol/L, 95% CI 0.9785–0.9946, p = 0.001), higher indirect bilirubin (OR 1.434, 95% CI 1.099–1.871, p = 0.008), a higher neutrophil-to-lymphocyte ratio (NLR; OR 1.139 per unit, 95% CI 1.021–1.271, p = 0.020) and lower albumin (OR 0.884 per g/L, 95% CI 0.782–0.998, p = 0.047) were independent predictors, whereas mtDNA-CN was not (OR 0.559, 95% CI 0.143–2.189, p = 0.404); rash was retained in the model with a consistent but borderline association (OR 3.053, 95% CI 0.943–9.881, p = 0.063). Multiple imputation and LASSO confirmed these findings. mtDNA-CN correlated with uric acid (Spearman ρ = 0.222, p = 0.013), showed no nonlinear (p = 0.348) or interaction effects, and its subgroup associations were not statistically heterogeneous. The clinical model achieved an AUC of 0.836 (bootstrap-corrected 0.812) and outperformed a Kobayashi-like score (AUC 0.603 in the same analysis set, 0.606 among all 134 patients; DeLong p < 0.001); adding mtDNA-CN did not improve discrimination (ΔAUC +0.009, p = 0.294). At the Youden-optimal risk threshold of 0.37, the nomogram yielded a sensitivity of 0.77 and specificity of 0.83; thresholds targeting 90% sensitivity (0.16; achieved 0.91) and 90% specificity (0.45; achieved 0.89) are provided for rule-out and rule-in strategies. Conclusions: mtDNA-CN is associated with IVIG resistance only in univariable analysis and does not add predictive value beyond routine laboratory variables. Hypo-uricemia emerged as a novel, independent predictor of IVIG resistance, biologically concordant with mtDNA-CN and consistent with oxidant-antioxidant interplay. A five-variable routine-laboratory nomogram predicted IVIG resistance with moderate-to-good, internally validated accuracy and superior performance to a Kobayashi-like score, but requires multicenter external validation before clinical use.
Authors
- Fan Ma (ORCID: https://orcid.org/0000-0003-1099-3299)
- Peng Yue (ORCID: https://orcid.org/0000-0002-9422-4595)
- Yifei Li (ORCID: https://orcid.org/0000-0002-3096-4287)
- Letao Zhou (ORCID: https://orcid.org/0009-0005-2001-6012)
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/jcm15229097
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China